COMP <GO>
IRWD vs JNJ // GROSS PROFIT MARGIN
Ironwood Pharmaceuticals Inc. (Class A) (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: IRWD 3
— JNJ 8
■ METRIC PARITY
LAST: $3.62 (+0.28%) • MKT CAP: $598.2M
gross-margins
—
LAST: $275.20 (+1.54%) • MKT CAP: $662.49B
gross-margins
67.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IRWD VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IRWD | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | — | 67.90% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 85.00% | 25.50% | +59.50 | IRWD | /roic <GO> |
| EV/EBITDA & P/E Valuation | 3.9x | 18.5x | -14.60 | IRWD | /valuation <GO> |
| Free Cash Flow Yield | 21.23% | 2.97% | +18.26 | IRWD | /fcf-yield <GO> |
| Operating Margin | 33.30% | 34.70% | -1.40 | JNJ | /operating-margins <GO> |
| Net Profit Margin | 8.10% | 28.50% | -20.40 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | -15.70% | 6.00% | -21.70 | JNJ | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 5.59 | -5.39 | JNJ | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 40.5 | 62.1 | -21.59 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.08 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 23.2x | 23.0x | +0.20 | JNJ | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $598.2M | $662.49B | -$661.89B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IRWD REV | JNJ REV | IRWD GROSS % | JNJ GROSS % | IRWD FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $296.2M | $94.19B | — | 67.9% | $127.0M | $19.70B |
| FY 2024 | $351.4M | $88.82B | — | 69.1% | $103.4M | $19.84B |
| FY 2023 | $442.7M | $85.16B | — | — | $183.4M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IRWD // BETA —
JNJ // BETA 1.08